The bill amends existing laws to require health insurance plans to provide comprehensive coverage for FDA-approved contraceptive drugs, devices, and related services without cost-sharing. This includes coverage for a 12-month supply of contraceptives, voluntary sterilization procedures, and clinical services related to contraception. The bill prohibits deductibles, coinsurance, copayments, or any other cost-sharing for these services, and ensures that coverage is the same for an enrollee's covered spouse or domestic partner and dependents. It also allows religious employers to exclude coverage for contraceptive methods that contradict their religious tenets, except when provided for non-contraceptive purposes, with a requirement to notify prospective enrollees of such exclusions.

Furthermore, the bill outlines the Department's responsibilities to monitor compliance, engage stakeholders in rule-making, conduct random reviews, and report annually on compliance efforts. It prohibits health plans from imposing utilization control or medical management that limits the supply of FDA-approved contraception to less than a twelve-month supply. The bill also adds a new section to the General Laws, requiring coverage for all FDA-approved contraceptive drugs and devices, with provisions for therapeutic equivalents and alternatives based on medical advisability and provider determination. The act is set to take effect upon passage, with provisions effective for health insurance contracts issued on or after January 1, 2024.

Statutes affected:
562: 27-18-57, 27-19-48, 27-20-43, 27-41-59